Clinical Trial Update: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety, tolerability, and preliminary efficacy of XH001 injection combined with a neoantigen vaccine–induced tumor-sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Neoantigen vaccine-induced tumor-specific T-cell injection
• XH001 (XH001)

Snippet

Sponsor: Jia Wei | Conditions: Advanced Gastric Cancer | Phase 1 | Status: RECRUITING